Abstract
To assess the effect of transforming growth factor beta 1 on the skin in vivo, we have targeted its expression to the epidermis of transgenic mice. To ensure that active TGF-beta 1 was expressed, we used a porcine TGF-beta 1 cDNA with mutations of Cys-223-->Ser and Cys-225-->Ser, which allow constitutive activation. Mice expressing the mutant transforming growth factor beta 1 transgene exhibited a marked phenotype at birth. The skin was very shiny and tautly stretched. These animals were rigid and appeared to be restricted in their ability to move and breathe; death occurred within 24 hr. Histologically, the most prominent features of the skin were a compact orthohyperkeratosis and a reduction in the number of hair follicles. Pulse-labeling studies with 5-bromodeoxyuridine demonstrated a marked reduction in the number of replicating cells in the epidermis and hair follicles. Thus, the macro- and microscopic appearance of these mice, as well as their neonatal lethality, most likely result from inhibition of normal skin development and suppression of epithelial cell proliferation by the overexpression of transforming growth factor beta 1.
MeSH Terms
Amino Acid Sequence
Animals
Animals, Newborn
Cysteine
DNA/genetics
Gene Expression
Immunohistochemistry
Introns
Mice
Mice, Transgenic
Microscopy, Electron
Mutagenesis, Site-Directed
RNA/genetics,isolation & purification
Reference Values
Serine
Skin/growth & development,pathology,ultrastructure
Swine
Transforming Growth Factor beta/analysis,genetics,physiology
Chemicals
Transforming Growth Factor beta
Serine
RNA
DNA
Cysteine
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Sellheyer K
Department of Cell Biology, Baylor College of Medicine, Houston, TX 77030.
Bickenbach J R
Rothnagel J A
Bundman D
Longley M A
Krieg T
Roche N S
Roberts A B
Roop D R
References (27)
27 references, click to expand
-
Epidermal cell culture.
Transplant Proc. 1980 Sep;12(3 Suppl 1):114-22
PMID: 6159705
-
Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes.
J Cell Biol. 1984 Apr;98(4):1397-406
PMID: 6201492
-
Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.
Cancer Res. 1986 Apr;46(4 Pt 2):2068-71
PMID: 2418960
-
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.
Proc Natl Acad Sci U S A. 1986 Jun;83(12):4167-71
PMID: 2424019
-
Growth modulation of mouse keratinocytes by transforming growth factors.
Cancer Res. 1988 Mar 15;48(6):1596-602
PMID: 2449957
-
Role of transforming growth factor beta in the maturation of human epidermal keratinocytes.
J Invest Dermatol. 1988 Mar;90(3):336-41
PMID: 2450142
-
Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes.
J Cell Biol. 1989 Feb;108(2):653-60
PMID: 2465297
-
Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice.
J Cell Biol. 1989 Feb;108(2):661-9
PMID: 2645303
-
Keratinocytes produce and are regulated by transforming growth factors.
Ann N Y Acad Sci. 1988;548:211-24
PMID: 2470296
-
TGF-beta stimulates primary human skin fibroblast DNA synthesis via an autocrine production of PDGF-related peptides.
J Cell Physiol. 1989 Aug;140(2):246-53
PMID: 2745561
-
Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins.
J Biol Chem. 1989 Aug 15;264(23):13660-4
PMID: 2474534
-
Transient synthesis of K6 and K16 keratins in regenerating rabbit corneal epithelium: keratin markers for an alternative pathway of keratinocyte differentiation.
Differentiation. 1989 Dec;42(2):103-10
PMID: 2483836
-
Differential expression of genes encoding TGFs beta 1, beta 2, and beta 3 during murine palate formation.
Dev Biol. 1990 Oct;141(2):456-60
PMID: 1698672
-
Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution.
J Clin Invest. 1990 Dec;86(6):1976-84
PMID: 2254455
-
The transforming growth factor-beta family.
Annu Rev Cell Biol. 1990;6:597-641
PMID: 2177343
-
Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis.
Development. 1991 Jan;111(1):117-30
PMID: 2015789
-
Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo.
Development. 1991 Jan;111(1):131-43
PMID: 1707784
-
Growth factors specifically alter hair follicle cell proliferation and collagenolytic activity alone or in combination.
Differentiation. 1990 Dec;45(3):168-78
PMID: 1965309
-
Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development.
J Cell Biol. 1991 Nov;115(4):1091-105
PMID: 1955457
-
In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2.
Development. 1990 Oct;110(2):609-20
PMID: 1723948
-
Post-transcriptional regulation of the human transforming growth factor-beta 1 gene.
J Biol Chem. 1992 Jul 5;267(19):13702-7
PMID: 1618868
-
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.
Nature. 1992 Oct 22;359(6397):693-9
PMID: 1436033
-
Transforming growth factor-beta: recent progress and new challenges.
J Cell Biol. 1992 Dec;119(5):1017-21
PMID: 1332976
-
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):770-4
PMID: 8421714
-
Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1.
J Immunol Methods. 1993 Jan 14;158(1):17-25
PMID: 8429213
-
Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene.
Mol Carcinog. 1993;7(2):99-110
PMID: 7681293
-
The development of mouse vibrissae in vivo and in vitro.
J Anat. 1952 Oct;86(4):342-56
PMID: 12999638